Asthma control and morbidity: a comparison of inhaler devices
Intended for healthcare professionals
Art & Science Previous     Next

Asthma control and morbidity: a comparison of inhaler devices

Jayne Haworth Practice nurse, St Anne’s, Lancashire

This study assessed the difference in efficacy and patient morbidity when asthma drug therapy was administered by either a dry powder device (DPD) or metered dose inhaler (MDI). It assessed 27 patients who had used an MDI for at least six months before transferring to a DPD because of inadequate inhaler technique. Documentary evidence was collected retrospectively from the medical records six months before and six months after the change and outcomes were measured by daily bronchodilator therapy, daily inhaled steroid therapy, frequency of night-time wakening due to asthma symptoms, and peak expiratory flow rates. Patient symptoms and asthma control were found to be improved by the correct delivery of medication via a DPD compared with an MDI.

Nursing Standard. 11, 1, 31-34. doi: 10.7748/ns1996.09.11.1.31.c2427

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more